A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

The U.S. Justice Department is accusing Walgreens of filling millions of prescriptions in the last decade and more without a ...

Private equity giant Blackstone has been making aggressive moves in the AI sector for several years and that trend will ...

The import of refurbished medical devices—largely high-tech equipment like MRIs, CT scans, and surgery robots—has been a ...

President-elect Donald Trump could take action in two key areas: restricting foreign organizations receiving U.S. funding ...

RFK Jr.'s call to ban TV advertisements for prescription drugs reignited support for a bipartisan bill that would mandate the retail prices of drugs be included in TV ads.

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry - where the American market accounts for ...

Inability to provide accurate and timely diagnosis is one of the major contributors to the misuse and overuse of ...